Antitumor and Immunopotentiating Activity of Polysaccharide PST001 Isolated from the Seed Kernel of Tamarindus indica: An In Vivo Study in Mice

Table 1

Group	No. of animals	Treatment	Day of administration	Days of observation
I	6 × 4 sets	(a)Vehicle	1	15
		(b) PST001
		(c) Reference drug
		(d) PST001+ reference drug on day 1
II	6 × 4 sets	(a) Vehicle	1–14— every day	15
		(b) PST001
		(c) Reference drug
		(d) PST001+ reference drug
III	6 × 4 sets	(a) Vehicle	8–21—every day	22
		(b) PST001
		(c) Reference drug
		(d) PST001+ reference drug after 7th day
IV	6 × 4 sets	Administerd for 7 days	1–7—every day	22
		(a) Vehicle
		(b) PST001
		(c) Reference drug
		(d) PST001+ reference drug + EAC/DLA on day 8

For Group I–Group III; DLA/EAC administered on first day. In Group IV; DLA/EAC administered on 8th day.